Skip to main content
Skip to main navigation
Invalid credentials.
Search for :
Product Development Strategy
Early Clinical Development
Phase I/IIa Clinical Trials
Phase II/III Clinical Trials
Interventional Phase IIIb/Phase IV Clinical Trials
Observational Research & Registries
Product Launch & Management
Market Access Solutions
Strategic Sales Outsourcing
Biopharmaceutical R&D
Biopharmaceutical Sales & Marketing
Biosimilars
Healthcare Payers & Providers
Medical Device & Diagnostics
Public Health & Government
Cardiovascular
Central Nervous System
Diabetes & Endocrinology
Infectious Diseases
Internal Medicine
Oncology
Early Phase Oncology
Translational Oncology
Pediatrics
Public Health Interest
Vaccines
Other Therapeutic Areas
Our Focus
Our Values
Our Heritage
Our Leadership
Ethics & Compliance
Investors
Global Locations
Facebook Twitter LinkedIn YouTube
Successful launch planning is a challenging process. With Allume, Quintiles helps achieve optimum value, maximize exclusivity periods and deliver target revenue for your new pharmaceutical or biotech product means. Read Fact Sheet
Dr. Amar Kureishi, Regional Chief Medical Officer, Asia-Pacific, Quintiles, discusses the main drivers behind the growth of biosimilars. Listen here
The work we do with the biopharmaceutical industry, payers and providers has a profound effect on extending patients’ lives and quality of life around the world. Learn More About Quintiles